Trademark: 87648954
Word
BEMZEFTA
Status
Dead
Status Code
606
Status Date
Monday, June 10, 2019
Serial Number
87648954
Mark Type
4000
Filing Date
Tuesday, October 17, 2017
Published for Opposition
Tuesday, May 15, 2018
Abandoned Date
Monday, June 10, 2019

Trademark Owner History
H. Lundbeck A-S - Owner At Publication

Classifications
5 Vaccines; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of dementia, Alzheimer's disorder and disease, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, apathy, epilepsy; pharmaceutical preparations and substances for the prevention and treatment of Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disorder and disease, insomnia, Parkinson's disorder and disease, falls, movement disorders and diseases, tremor, schizophrenia, bipolar disorder and disease, mania, ADHD, PTSD, agitation, aggression, autism, melancholy, OCD, Tourette's syndrome, progressive supranuclear palsy (PSP), restlessness, akathisia, somnolence, nausea, cancer, migraine, alcoholism and dependency; diagnostic agents, reagents, preparations and substances for medical purposes; all of the foregoing goods excluding pharmaceutical preparations and substances for the treatment of autoimmune diseases and immunologic conditions
10 Medical apparatus and instruments for use in diagnosing and monitoring vital signs of patients with psychiatric and neurological disorders and diseases, dementia, Alzheimer's disorder and disease, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disorder and disease, insomnia, Parkinson's disorder and disease, falls, movement disorders and diseases, tremor, schizophrenia, bipolar disorder and disease, mania, ADHD, PTSD, agitation, aggression, autism, melancholy, OCD, Tourette's syndrome, progressive supranuclear palsy (PSP), restlessness, akathisia, fatigue, somnolence, nausea, cancer, migraine, pain, alcoholism and dependency; injection devices for pharmaceuticals, syringes and needles for injections and medical purposes; integrated medical systems, namely, medical diagnostic imaging apparatus and software sold as a unit therewith for managing, measuring, monitoring, assessing, controlling, collecting, storing and examining patient and client data and information captured by the medical system in web-based physical, psychological and neurological examinations conducted at a distance and at a clinic; medical apparatus and units for dosage, measuring and monitoring, namely, drug delivery devices and systems

Trademark Events
Jun 10, 2019
Abandonment Notice E-Mailed - No Use Statement Filed
Jun 10, 2019
Abandonment - No Use Statement Filed
Nov 6, 2018
Noa E-Mailed - Sou Required From Applicant
Sep 23, 2018
Extension Of Time To Oppose Process - Terminated
Jul 25, 2018
Changes/Corrections After Pub Approval Entered
Jul 25, 2018
Assigned To Petition Staff
Jun 26, 2018
Teas Post Publication Amendment Received
May 16, 2018
Extension Of Time To Oppose Received
May 15, 2018
Official Gazette Publication Confirmation E-Mailed
May 15, 2018
Published For Opposition
Apr 25, 2018
Notification Of Notice Of Publication E-Mailed
Apr 9, 2018
Assigned To Lie
Apr 2, 2018
Approved For Pub - Principal Register
Mar 15, 2018
Examiner's Amendment Entered
Mar 15, 2018
Notification Of Examiners Amendment E-Mailed
Mar 15, 2018
Examiners Amendment E-Mailed
Mar 15, 2018
Examiners Amendment -Written
Jan 19, 2018
Notification Of Priority Action E-Mailed
Jan 19, 2018
Priority Action E-Mailed
Jan 19, 2018
Priority Action Written
Jan 19, 2018
Assigned To Examiner
Oct 26, 2017
New Application Office Supplied Data Entered In Tram
Oct 20, 2017
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24